MIG Inhibitors
The chemical class termed MIG inhibitors constitutes a multifaceted group of compounds characterized by their capability to modulate the activity of Monokine Induced by Gamma Interferon (MIG), also identified as CXCL9, a chemokine involved in the intricate orchestration of immune responses. At the heart of this class lies a diverse array of small molecules and agents, each uniquely engineered to interfere with the cascade of molecular events associated with MIG's functioning. Central to MIG's role is its interaction with the CXCR3 receptor, a key player expressed on the surfaces of immune cells. MIG inhibitors, as perturbing protagonists in this interaction, enact their influence by subtly yet effectively disrupting the binding equilibrium between MIG and CXCR3. The interplay of MIG and its receptor is fundamental for summoning immune cells to areas of inflammation, thereby precipitating vital immune responses. MIG inhibitors, through their distinctive mechanisms, deftly disrupt this chemotactic communication, curbing the migration of immune cells to inflammatory foci. These inhibitors can act on various facets of MIG's regulatory circuitry, orchestrating a symphony of modulation that extends from the production and secretion of MIG to the modulation of downstream signaling pathways initiated upon its receptor binding.
The chemical diversity within the MIG inhibitor class is striking, with compounds exhibiting a wide array of structural blueprints and modulatory mechanisms. These compounds, with their intricate architectures, carry out a nuanced dance with MIG and its receptor, potentially affecting the binding affinity of MIG to CXCR3 or modifying the intracellular signaling cascades that ensue. Such a dynamic interplay underscores the complexity of the immune response modulation achieved by MIG inhibitors. The exploration of MIG inhibitors occupies a prominent place within the realm of research, as their potential to fine-tune immune cell trafficking and immune responses bears significant implications.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BIBF1120 | 656247-17-5 | sc-364433 sc-364433A | 5 mg 10 mg | $184.00 $321.00 | 2 | |
Primarily used for idiopathic pulmonary fibrosis, nintedanib has been shown to inhibit multiple growth factors and cytokines, including MIG. It can potentially impact immune cell recruitment to the inflamed tissue. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Known for its use in inflammatory bowel diseases, sulfasalazine has been shown to inhibit MIG production and secretion, thus possibly contributing to its anti-inflammatory effects. | ||||||
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $90.00 $146.00 $469.00 $791.00 | 18 | |
This chemotherapy drug, in addition to its direct anticancer effects, can also modulate the immune system. It has been reported to suppress the production of MIG and other chemokines. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressive drug commonly used in organ transplantation and autoimmune conditions, cyclosporine can indirectly impact MIG levels by affecting immune cell function and cytokine production. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Widely used for autoimmune diseases like rheumatoid arthritis, methotrexate can modulate immune responses and potentially influence MIG production and activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Another immunosuppressive drug, sirolimus, can inhibit the production of various cytokines, including MIG, by interfering with signaling pathways within immune cells. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
While infamous for its history of causing birth defects, thalidomide has found use in certain medical conditions, including autoimmune disorders. It has been suggested that thalidomide can modulate cytokine production, possibly including MIG. | ||||||